Home

Lincoln Alternative Strategies reported a 0% stake in Calidi Biotherapeutics CLDI · 0 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
0%
Last report
14.46% · filed 25/08/27
Shares held
0 sh
Class
Common stock, par value $0.0001 per share
Event date
25/09/18
Filed
26/02/10

0% stake · fully exited

Stake
0%
Last report
14.46%
Since last report
−14.5pp

Calidi Biotherapeutics trades, last 26 weeks

What else happened in Calidi Biotherapeutics around then

Filed or reported within 30 days of the trade day · 25/08/19~25/10/18

Lincoln Alternative Strategies's other 5% stake reports